According to a recent LinkedIn post from Latent, WVU Medicine’s Chief Pharmacy Officer Todd Karpinski is scheduled to speak at Becker’s Healthcare CPO Summit about how pharmacy leadership is influencing C‑suite dynamics. The post highlights reported operational improvements in medication access at WVU Medicine, including faster case turnaround and reduced review times for Highmark and Caremark cases.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that pharmacy-focused process optimization is yielding measurable gains, with cited turnaround falling from more than 24 hours to 1–2 hours and overall review time reportedly cut to minutes. For investors, these metrics may signal growing demand for workflow and clinical decision solutions that can demonstrably improve payer interactions and patient access, potentially reinforcing Latent’s positioning in healthcare technology and its relevance to health system efficiency initiatives.